Portal de Periódicos da CAPES

Oral Ibuprofen for Treatment of Patent Ductus Arteriosus: More than a Cheap Alternative

2012; Karger Publishers; Volume: 102; Issue: 3 Linguagem: Inglês

10.1159/000339552

1661-7819

Ömer Erdeve, Sadık Yurttutan, Рамазан Оздемир, Uǧur Dilmen,

Congenital Heart Disease Studies

Letters| July 07 2012 Oral Ibuprofen for Treatment of Patent Ductus Arteriosus: More than a Cheap Alternative?: Concerning the Article by R. Neumann et al.: Oral Ibuprofen versus Intravenous Ibuprofen or Intravenous Indomethacin for the Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis [Neonatology 2012;102:9–15] Subject Area: Women's and Children's Health Omer Erdeve; Omer Erdeve aDivision of Neonatology, Department of Pediatrics, Ankara University School of Medicine and Search for other works by this author on: This Site PubMed Google Scholar Sadık Yurttutan; Sadık Yurttutan bDivision of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey Search for other works by this author on: This Site PubMed Google Scholar Ramazan Ozdemir; Ramazan Ozdemir bDivision of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey Search for other works by this author on: This Site PubMed Google Scholar Ugur Dilmen Ugur Dilmen bDivision of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey Search for other works by this author on: This Site PubMed Google Scholar Neonatology (2012) 102 (3): 196. https://doi.org/10.1159/000339552 Article history Received: May 03 2012 Accepted: May 20 2012 Published Online: July 07 2012 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Omer Erdeve, Sadık Yurttutan, Ramazan Ozdemir, Ugur Dilmen; Oral Ibuprofen for Treatment of Patent Ductus Arteriosus: More than a Cheap Alternative?: Concerning the Article by R. Neumann et al.: Oral Ibuprofen versus Intravenous Ibuprofen or Intravenous Indomethacin for the Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis [Neonatology 2012;102:9–15]. Neonatology 1 September 2012; 102 (3): 196. https://doi.org/10.1159/000339552 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsNeonatology Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. © 2012 S. Karger AG, Basel2012Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.